Novavax Inc. Stock Rises Thursday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) inched 0.58% higher to $17.32 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.13% to 11,082.00 and the Dow Jones Industrial Average rising 0.55% to 33,781.48. This was the stock's second consecutive day of gains. Novavax Inc. closed $219.18 below its 52-week high ($236.50), which the company achieved on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.02% to $177.20, Pfizer Inc. (PFE) rose 3.07% to $51.78, and Merck & Co. Inc. (MRK) rose 0.69% to $110.85. Trading volume (3.9 M) remained 1.2 million below its 50-day average volume of 5.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2022.
(END) Dow Jones Newswires
December 08, 2022 17:25 ET (22:25 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.